SAM
TRML

Sectoral Asset Management’s Tourmaline Bio TRML Stock Holding History

Sectoral Asset Management’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-116,510
Closed -$1.86M – 94
2025
Q2 		$1.86M Buy
+116,510
New +$1.89M 1.23% 30
2022
Q3 		– Sell
-22,862
Closed -$1.03M – 117
2022
Q2 		$1.03M Hold
22,862
– – 0.21% 87
2022
Q1 		$2.25M Sell
22,862
-3,196
-12% -$299K 0.4% 78
2021
Q4 		$3.98M Sell
26,058
-55,358
-68% -$8.19M 0.6% 64
2021
Q3 		$11M Buy
81,416
+10,316
+15% +$1.41M 0.92% 40
2021
Q2 		$10.4M Buy
+71,100
New +$10.9M 0.85% 51

Other funds holding TRML

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Sectoral Asset Management's TRML Position: Q3 2025 in Review

Sectoral Asset Management sold out of Tourmaline Bio (TRML) in Q3 2025, closing a stake of 116,510 shares — an estimated $1.86M sold.

Sectoral Asset Management first reported a position in TRML in Q2 2021 and held it in 6 quarters. The position peaked at $11M in Q3 2021. 134 funds tracked by Wall St. Rank hold TRML as of Q3 2025.

  • Sectoral Asset Management reported no remaining Tourmaline Bio position as of Q3 2025 after selling out during the quarter.
  • Sectoral Asset Management sold 116,510 Tourmaline Bio shares in Q3 2025, an estimated $1.86M.
  • Sectoral Asset Management first reported a position in Tourmaline Bio in Q2 2021 and held it in 6 quarters.
  • Sectoral Asset Management's Tourmaline Bio position peaked at $11M in Q3 2021.
  • 134 funds tracked by Wall St. Rank held Tourmaline Bio as of Q3 2025.

Based on Sectoral Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.